查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1146146

光療市場 - 增長、趨勢、COVID-19 影響和預測（2022-2027 年）

Light Therapy Market - Growth, Trends, and Forecasts (2022 - 2027)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在研究期間（2022-2027 年），光療市場預計將以 4.5% 的顯著複合年增長率增長。

最近，各國面臨著 COVID-19 的巨大威脅。 COVID-19 對所有主要器官系統都有重大影響。根據 2021 年 4 月發表的論文《藍光的力量——從 COVID-19 中恢復的光療》，藍光療法可提高 B-內啡□水平，降低收縮壓、內皮功能和動脈可能對一系列這些持續症狀有益，對改善僵硬有顯著影響。研究表明藍光療法在治療 COVID-19 應用患者方面的益處促進了採用，增加了對光療法產品和服務的需求。隨著光療的益處和應用的擴大，光療市場預計將在 COVID-19 之後增長。

研究的市場增長驅動因素包括皮膚相關疾病、精神疾病負擔增加、投資增加、產品發布增加、研發活動增加以及主要市場參與者採用關鍵戰略。

抑鬱症、焦慮症和阿爾茨海默病等精神疾病的負擔日益加重，對治療這些疾病的藥物的需求也在增加，而光療法正被用於治療此類疾病。例如，根據世界衛生組織（WHO）2021 年 9 月發表的一篇論文，抑鬱症是一種常見的精神疾病，全球估計有 5.0% 的成年人患有抑鬱症。它是全球殘疾的主要原因之一。光療法在抑鬱症治療中的應用越來越多，這些疾病的高患病率推動了市場的發展。

主要參與者採用的關鍵戰略，例如兼併、收購、合作、投資和創新，可能會帶來利潤豐厚的市場增長。例如，2022 年 3 月，10X Health System 與 DaVinci Medical 合作，將 Superhuman Protocol 推向市場。 Superhuman Protocol 讓客戶體驗全身 360 度全方位解決方案，從終生疏忽中恢復過來，自然地增強健康和表現。該協議分三個步驟設計，包括促進三磷酸腺甘 (ATP) 產生的 celalite 治療床。因此，推動產品創新的合作夥伴關係將引領市場增長。

此外，2021 年 11 月，PHLECS 從 Metropoolregio Eindhoven 獲得了 50,000 歐元的贈款，用於開展一個開發新一代光療無藍光-紫外線醫療設備的項目：Full Body Home Connected。該設備可以捕獲患者的生物醫學數據，以實現個性化治療和未來基於人工智能的服務。因此，對所研究市場的巨額投資表明該市場具有巨大的創新和增長潛力，從而推動了研究期間的市場。

因此，由於上述因素，研究涵蓋的市場預計在研究期間將顯著增長。然而，與光療相關的副作用增加和產品召回預計將阻礙研究期間的市場增長。

主要市場趨勢

預計紅燈部分將在預測期內佔據最大的市場份額

紅光療法 (RLT) 或光生物調節是一種很有前途的新療法，可用於治療皺紋、發紅、痤瘡、疤痕和其他衰老跡象。這種治療方法是無毒的、非侵入性的，並且比一些局部皮膚治療方法更溫和。紅光療法 (RLT) 是一種據報導使用低波長紅光改善皮膚外觀和治療其他疾病的治療方法。

新紅光療法產品和服務的推出、RLT 的日益普及、大規模投資、主要參與者採用關鍵戰略以及不斷增長的研發研究預計將推動研究中的市場。

2021 年 10 月，Lifepro 推出了其紅光療法系列，以提供價格具有競爭力的非侵入性健康護理。每種產品都針對身體的不同部位，並提供一套完整的套件來支持不同的疾病和健康目標。市場參與者推出此類療法正在增加可及性並促進市場增長。

領先公司採用夥伴關係、合作和投資等重要戰略將推動研究目標細分市場。例如，2022 年 2 月，UFC 表演研究所和 GameDay Ready 恢復區建立了合作夥伴關係，為所有 UFC 運動員提供紅光療法，以提高他們的表現。紅光通過增加三磷酸腺甘 (ATP) 的產生和減少劇烈運動後的氧化應激，幫助身體在細胞水平上恢復最佳性能。

2022 年 2 月，Arizona Coyotes 與亞利桑那州的一家公司 Mito Red Light Inc. 合作，該公司開發紅光療法產品以支持恢復、表現和整體健康。這樣，紅光療法在各個領域的立即採用將極大地促進市場的增長。

此外，越來越多的研究和開發證明紅光療法對各種疾病的有效性將促進市場研究。例如，根據clinicaltrials.gov，2021年3月，中山眼科中心（中山大學）對近視進展迅速的角膜塑形術治療無反應者重複低水平紅光控制近視。開始評估治療（RLRL）和角膜塑形術（Ortho-k）的輔助效果。因此，此類研究的結果有望提高其適應性並帶來豐厚的市場增長。

因此，由於上述因素，研究部門有望為市場的大幅增長做出貢獻。

北美在市場中佔有很大份額，預計在預測期內也會如此

北美光療市場增長的主要驅動力是心理健康和皮膚相關疾病負擔的增加、研發活動的增長、投資的增加、產品發布的增加、主要市場參與者的重大舉措等。

皮膚相關疾病（如尋常痤瘡、銀屑病和白癜風）的負擔日益加重，預計這將推動光療市場對這些疾病的治療。根據 2021 年 8 月發表的 Medscape 文章“關於美國尋常痤瘡的發病率”，痤瘡是美國最常見的皮膚病，每年影響 5000 萬人。...尋常痤瘡（粉刺）在某些時候影響了美國 80% 的人。嚴重的痤瘡影響 20% 的人，據說會留下長期的身心傷疤。因此，尋常痤瘡的高流行有望推動該國市場的增長。

在該地區推出的光療產品和服務也將顯著推動市場。例如，2021 年 11 月，Vital Red Light 將推出一系列新的家用、專業級紅色和近紅外光療設備，讓患者能夠從舒適區獲得光療治療。此外，2022 年 2 月，Oralucent 推出了一款獲得多項專利的藍光和紅光光療牙刷，用於安全有效地解決美白和其他常見牙齒問題。

此外，增加合作夥伴關係和增加市場主要參與者的投資等戰略也將推動該地區的創新，從而推動該地區的市場。例如，2021 年 10 月，Zerigo Health 在由 7wireVentures 領投的一輪融資中獲得了 4300 萬美元。這將幫助 Zerigo 擴大其光療系統的可用性，使其能夠覆蓋美國更大比例的慢性皮膚病患者。

該地區研究活動的進一步積極成果也將顯著推動市場。例如，根據 Clinicaltrials.gov 的數據，該研究預計將於 2022 年 4 月開始，並由波特蘭 VA 醫學中心和俄勒岡健康與科學大學於 2026 年 8 月完成。本研究旨在評估晨光療法改善腦外傷退伍軍人睡眠的可行性和初步療效。

因此，由於上述因素，預計所研究的市場將在北美帶來利潤豐厚的增長。

競爭格局

這個市場分散且競爭激烈。關鍵市場參與者很容易採用聯合研究、併購、合作夥伴關係和投資等關鍵戰略來推動市場發展。市場參與者包括 Koninklijke Philips N.V.、Verilux, Inc.、Northern、Light Technologies、Beurer、Zepter International 等。

其他特典

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第 1 章介紹

  • 研究假設和市場定義
  • 調查範圍

第 2 章研究方法

第 3 章執行摘要

第 4 章市場動態

  • 市場概覽
  • 市場促進因素
    • 皮膚病和精神疾病負擔不斷增加
    • 啟動研發
  • 市場抑制因素
    • 光療帶來的副作用和產品召回增加
  • 五力分析分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於金額，單位：百萬美元）

  • 按產品類型
    • 燈箱
    • 落地燈/檯燈
    • 輕便的遮陽板
    • 黎明模擬器
    • 光療儀
    • 手持設備
  • 按光源類型
    • 白光
    • 藍光
    • 紅燈
    • 其他（綠燈、黃燈）
  • 按用途
    • 維生素 D 缺乏症
    • 精神疾病
    • 皮膚病
    • 新生兒黃疸
  • 按最終用戶
    • 皮膚科診所
    • 家庭醫療
    • 其他（工作場所、沙龍等）
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東和非洲
      • 海合會
      • 南非
      • 其他中東和非洲
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第 6 章競爭格局

  • 公司簡介
    • Koninklijke Philips N.V.
    • Verilux, Inc.
    • Northern Light Technologies
    • Beurer
    • Zepter International
    • PhotoMedex, Inc.
    • Nature Bright
    • Lucimed SA
    • Carex
    • Lumie
    • Revian, Inc.
    • BioPhotas

第 7 章市場機會和未來趨勢

簡介目錄
Product Code: 90795

The Light Therapy Market is expected to grow at a significant CAGR of 4.5% during the study period (2022-2027).

In recent times, countries have faced a huge threat of COVID-19. COVID-19 has a considerable effect on all major organ systems. According to the article "The Power of Blue Light - Phototherapy for Recovering From COVID-19," published in April 2021, blue light therapy had a significant influence on the increase of B-endorphin levels, reduction of systolic blood pressure, improving endothelial function and arterial stiffness and hence, blue light therapy could be beneficial for a range of these persistent symptoms. With research studies depicting the advantages of blue light therapy in treating patients with COVID-19 applications, it was readily adopted, boosting the demand for light therapy products and services. With light therapy's expanding benefits and applications, the market is expected to grow post-COVID-19.

The factors propelling the studied market growth are the growing burden of skin-related disorders, mental health disorders, rising investments, increasing product launches, growing research and development activities, and the adoption of key strategies by major market players.

The growing burden of mental health disorders such as depression, anxiety disorders, Alzheimer's diseases, and others is increasing the demand for its therapeutics, and light therapy is used to treat such disorders. For instance, as per the article published by World Health Organization (WHO) in September 2021, depression is a common mental disorder, and it is estimated that 5.0% of adults suffer from depression globally. It is one of the leading causes of disability worldwide. Increasing usage of light therapy in treating depression and a high prevalence of these diseases will propel the market.

The key strategies adopted by major players, such as mergers, acquisitions, partnerships, investments, and technological innovation, will lead to lucrative market growth. For instance, in March 2022, 10X Health System partnered with DaVinci Medical to bring the Superhuman Protocol to the market. The Superhuman Protocol allows the clients to experience a whole-body 360 solution to restore a lifetime of neglect and naturally boost health and performance. This protocol is designed in three steps, including the Thera Light therapy bed to accelerate the production of Adenosine Triphosphate (ATP). Thus, partnerships boosting product innovation will lead the market towards growth.

Additionally, in November 2021, PHLECS received EUR 50,000 grant from Metropoolregio Eindhoven to initiate the development project of a new generation of phototherapy blue light - UV-free medical device: the Full Body Home Connected. This device can capture patient biomedical data for personalized treatment and enable future artificial intelligence-based services. Thus, huge investments in the studied market indicate that market has huge potential for innovation and growth, thus driving the market during the study period.

Therefore, owing to the aforementioned factors, the studied market is expected to grow significantly during the study period. However, increasing side effects associated with light therapy and product recalls are expected to hinder the market growth during the study period.

Key Market Trends

Red Light Segment is Expected to Account for the Largest Market Share During the Forecast Period

Red light therapy (RLT) or photobiomodulation is an emerging treatment showing promise in treating wrinkles, redness, acne, scars, and other signs of aging. This therapy is not toxic, not invasive, and not as harsh as some topical skin treatments. Red light therapy (RLT) is a treatment that uses low wavelength red light to reportedly improve the skin's appearance and treat other medical conditions.

Launching new red light therapy products and services, increased adoption of RLT, huge investments, adoption of key strategies by major players, and rising research and development studies are expected to boost the studied market.

In October 2021, Lifepro launched its Red Light Therapy line to provide access to non-invasive wellness care at a competitive price. Each product targets different points on the body to provide a full suite of support for various ailments and wellness goals. Such launches of therapies by market players increase accessibility and thus boosts the market's growth.

Adopting key strategies such as partnerships and collaborations, investments, and others by major players will boost the studied segment. For instance, in February 2022, UFC Performance Institute and GameDay Ready Recovery Zone entered into a partnership to provide red light therapy to all UFC athletes, which will help in enhancing their performance. Red light helps return the body to optimal performance at a cellular level by Increasing adenosine triphosphate (ATP) production and reducing oxidative stress following challenging workouts.

In February 2022, the Arizona Coyotes partnered with Mito Red Light Inc., an Arizona-based company that develops red light therapy products to support recovery, performance, and overall health and wellness. Thus, the ready adoption of red-light therapy in various areas will drive the market growth significantly.

Additionally, rising research and development studies proving the efficacies of red light therapy in various diseases will boost the market studies. For instance, as per clinicaltrials.gov, a study was initiated by Zhongshan Ophthalmic Center, Sun Yat-sen University, in March 2021 to evaluate the adjunctive effect of repeated low-level red-light therapy (RLRL) and orthokeratology (ortho-k) on myopia control in ortho-k non-responders who have undergone ortho-k treatment but were still experiencing fast myopia progression. Thus, results from such research studies will increase its adaptability, leading to lucrative market growth.

Thus, due to the above-mentioned factors, the studied segment is expected to contribute to the significant growth of the market.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same Over the Forecast Period

The primary driving factors for the growth of the North American light therapy market are the growing burden of mental health and skin-related disorders, growing research and development activities, increasing investments, rising product launches, and key initiatives taken by the key market players.

The rising burden of skin-related disorders such as acne vulgaris, psoriasis, vitiligo, and others is expected to boost the light therapy market as they treat these disorders. According to a Medscape article published in August 2021 titled "How common is acne vulgaris in the United States?" acne is the most common skin condition in the United States, affecting 50 million people each year. Acne vulgaris affects 80% of people in the United States at some point. Severe acne affects 20% of people, causing long-term physical and mental scarring. Thus, the high prevalence of acne vulgaris is expected to boost the market growth in the country.

Launching the region's light therapy products and services will also drive the market significantly. For instance, in November 2021, Vital Red Light launched a new collection of at-home, professional-grade red and near-infrared light therapy devices, which will provide patients the accessibility to light therapy treatments from the comfort of their zone. Additionally, in February 2022, Oralucent launched its multi-patented, blue, and red-light emitting phototherapy toothbrush to address whitening and other common dental concerns safely and effectively.

Moreover, strategies such as rising partnerships and increasing investments by major players in the market will also boost innovation in the region, thereby boosting the market in the region. For instance, in October 2021, Zerigo Health received USD 43 million in the funding round led by 7wireVentures. This will help Zerigo in scaling up the availability of its phototherapy system and allow it to reach an even greater percentage of people living with chronic skin conditions in the United States.

The positive results from the research activities in the region will also drive the market significantly. For instance, as per Clinicaltrials.gov, a study was initiated by Portland VA Medical Center and Oregon Health and Science University in April 2022 and is estimated to be completed by August 2026. This study aimed to assess the feasibility and preliminary efficacy of morning bright light therapy to improve sleep in Veterans with traumatic brain injury.

Therefore, the studied market is expected to lead to lucrative growth in North America due to the above-mentioned factors.

Competitive Landscape

The studied market is fragmented and moderately competitive. Key strategies such as collaborations, mergers and acquisitions, partnerships, and investments, among others, are readily adopted by key market players, boosting the market. The major players in the market include Koninklijke Philips N.V., Verilux, Inc., Northern, Light Technologies, Beurer, and Zepter International, among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Burden of Skin and Mental Health Disorders
    • 4.2.2 Increasing Research and Development Activities
  • 4.3 Market Restraints
    • 4.3.1 Increasing Side Effects Due to Light Therapy and Product Recalls
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - in USD Million)

  • 5.1 By Product Type
    • 5.1.1 Light Box
    • 5.1.2 Floor and Desk Lamps
    • 5.1.3 Light Visor
    • 5.1.4 Dawn Simulator
    • 5.1.5 Light Therapy Bulbs
    • 5.1.6 Handheld Devices
  • 5.2 By Light Type
    • 5.2.1 White Light
    • 5.2.2 Blue Light
    • 5.2.3 Red Light
    • 5.2.4 Others (Green and Yellow Light)
  • 5.3 By Application
    • 5.3.1 Vitamin D Deficiency
    • 5.3.2 Mental Health Disorders
    • 5.3.3 Skin Disorders
    • 5.3.4 Neonatal Jaundice
  • 5.4 By End User
    • 5.4.1 Dermatology Clinics
    • 5.4.2 Home Care Settings
    • 5.4.3 Others (Workplace, Salons, etc.)
  • 5.5 Geography
    • 5.5.1 North America
      • 5.5.1.1 United States
      • 5.5.1.2 Canada
      • 5.5.1.3 Mexico
    • 5.5.2 Europe
      • 5.5.2.1 Germany
      • 5.5.2.2 United Kingdom
      • 5.5.2.3 France
      • 5.5.2.4 Italy
      • 5.5.2.5 Spain
      • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
      • 5.5.3.1 China
      • 5.5.3.2 Japan
      • 5.5.3.3 India
      • 5.5.3.4 Australia
      • 5.5.3.5 South Korea
      • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle-East and Africa
      • 5.5.4.1 GCC
      • 5.5.4.2 South Africa
      • 5.5.4.3 Rest of Middle-East and Africa
    • 5.5.5 South America
      • 5.5.5.1 Brazil
      • 5.5.5.2 Argentina
      • 5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Koninklijke Philips N.V.
    • 6.1.2 Verilux, Inc.
    • 6.1.3 Northern Light Technologies
    • 6.1.4 Beurer
    • 6.1.5 Zepter International
    • 6.1.6 PhotoMedex, Inc.
    • 6.1.7 Nature Bright
    • 6.1.8 Lucimed SA
    • 6.1.9 Carex
    • 6.1.10 Lumie
    • 6.1.11 Revian, Inc.
    • 6.1.12 BioPhotas

7 MARKET OPPORTUNITIES AND FUTURE TRENDS